184 open real-world evidence positions
GE HealthCare
Tempus
AstraZeneca
Novartis
Merck & Co.
Moderna
Neurocrine Biosciences
Bristol Myers Squibb
Pierre Fabre
Gilead Sciences
Johnson & Johnson
Biogen